3rd generation glp 1 GLP-3' retatrutide drug delivers major weight loss breakthrough in trials Comment “Curious” for the deep

Diabetes Care 39(2):231241 Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B, Lingvay I, Thomsen M, Wadden TA, Wharton S, Wilding JPH, Rubino D (2020) Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5

Polyakova, I

Recent research shows that GLP-1 medications help lowerinflammation, leading to fewer flares, less joint pain and stiffness, better movement, and more energy

Some of the most common side effects include swelling, bruising, and redness at the injection site

Diabetes 68(Supplement 1):58-OR van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WHM (2014) Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

Lipid improvements are also more pronounced with tirzepatide